Bionano Genomics, Inc. (BNGO) Gross margin 2017–2025
Bionano Genomics, Inc. (BNGO) gross margin by fiscal year — reported gross profit divided by reported revenue.
46.3%FY2025 · since FY2017: 36.6% → 46.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 46.3% | +45.0 pp |
| FY2024 | 1.2% | -25.3 pp |
| FY2023 | 26.5% | +5.1 pp |
| FY2022 | 21.4% | -0.2 pp |
| FY2021 | 21.5% | -11.1 pp |
| FY2020 | 32.6% | -0.6 pp |
| FY2019 | 33.2% | +5.8 pp |
| FY2018 | 27.4% | -9.1 pp |
| FY2017 | 36.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BNGO financial trends
BNGO RevenueBNGO Net incomeBNGO Net marginBNGO Gross profitBNGO Operating incomeBNGO Operating marginBNGO Operating cash flowBNGO Free cash flowBNGO Capital expendituresBNGO Return on equityBNGO Stock buybacksBNGO Dividends paidBNGO Total assetsBNGO Total liabilitiesBNGO Shareholders’ equityBNGO overview →